Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Publ. Version/Full Text
Research data
DOI
PMC
 |
Open Access Gold |
|
as soon as is submitted to ZB.
Generation of human induced pluripotent stem cell lines carrying a heterozygous and homozygous PRKD1 c.1774G > A genetic variant causing syndromic congenital defects.
Stem Cell Res. 92:103937 (2026)
Protein kinase D1 (PRKD1) is a serine threonine kinase with roles in the regulation of embryonic development, contractility, vesicle transport and cytoskeleton organization. Consequently, variants in PRKD1 that alter its kinase activity are associated with severe anomalies, manifesting as syndromic congenital defects in patients. To investigate the molecular pathomechanisms underlying PRKD1 genetic variants, the patient-derived PRKD1 p.G592R (c.1774 G > A) mutation was introduced in heterozygous and homozygous configuration into the human induced pluripotent stem cell line (AICS-0031-035:WTC-mTagRFPT-TUBA1B) with CRISPR/Cas9 technology and were thoroughly validated. These hiPSC lines constitute a valuable platform for dissecting the molecular consequences of impaired PRKD1 signaling.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Induced Pluripotent Stem Cell ; Embryonic Stem Cell ; Mutation ; Cell Culture ; Kinase ; Protein Kinase Domain ; Serine ; Threonine
ISSN (print) / ISBN
1873-5061
e-ISSN
1876-7753
Journal
Stem Cell Research
Quellenangaben
Volume: 92,
Article Number: 103937
Publisher
Elsevier
Reviewing status
Peer reviewed
Institute(s)
Institute of Experimental Genetics (IEG)